Veterinary Medicine Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Medicine Market, By Product

7.1.  Veterinary Medicine Market, by Product Type, 2020-2030

7.1.1.    Biologics

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Pharmaceuticals

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Medicated Feed Additives

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Veterinary Medicine Market, By Mode of Delivery

8.1.  Veterinary Medicine Market, By Mode of Delivery, 2020-2030

8.1.1.    Oral

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Parenteral

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Others (Topical, carrier)

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Veterinary Medicine Market, By Animal Type

9.1.  Veterinary Medicine Market, By Animal Type, 2020-2030

9.1.1.    Production

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Companion

9.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Veterinary Medicine Market, By End-use Type

10.1.        Veterinary Medicine Market, By End-use Type, 2020-2030

10.1.1.  Reference Laboratories

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Point-of-care testing/In-house testing

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Veterinary Hospitals & Clinics

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Veterinary Medicine Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2030)

11.1.2.  Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.1.3.  Market Revenue and Forecast, By Animal Type (2016-2030)

11.1.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.1.5.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.1.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.1.6.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.1.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2030)

11.2.2.  Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.2.3.  Market Revenue and Forecast, By Animal Type (2016-2030)

11.2.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.2.5.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.2.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.2.6.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.2.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.2.7.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.2.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.2.8.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.2.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2030)

11.3.2.  Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.3.3.  Market Revenue and Forecast, By Animal Type (2016-2030)

11.3.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.3.5.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.3.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.3.6.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.3.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.3.7.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.3.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.3.8.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.3.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2030)

11.4.2.  Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.4.3.  Market Revenue and Forecast, By Animal Type (2016-2030)

11.4.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.4.5.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.4.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.4.6.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.4.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.4.7.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.4.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.4.8.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.4.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2030)

11.5.2.  Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.5.3.  Market Revenue and Forecast, By Animal Type (2016-2030)

11.5.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.5.5.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.5.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.2.      Market Revenue and Forecast, By Mode of Delivery (2016-2030)

11.5.6.3.      Market Revenue and Forecast, By Animal Type (2016-2030)

11.5.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

Chapter 12.  Company Profiles

12.1.              Merck Animal Health

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Ceva Sante Animale

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Vetoquinol S.A.

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Zoetis

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Boehringer Ingelheim GmbH

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Elanco

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Nutreco N.V.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Virbac

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Kindred Biosciences, Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Biogenesis Bago

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Indian Immunologicals Ltd.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Neogen Corporation

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Hester Biosciences

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           Philbro Animal Health

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms